Bérengère Macabeo

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Cross Sectional

Diffuse Large B Cell Lymphoma

Clinical Evaluation

Top Venues

PharmacoEconomics - open

Journal of medical economics

Journal of market access & health policy

This page only lists publications with an associated author ORCID identifier.

Publications

Arie Barlev, Heiner Zimmermann, Norma Guzman-Becerra, Aditi Mehta, Baodong Xing, Bérengère Macabeo, Marion Thivolet, M Alan Brookhart
Comparative analysis of tabelecleucel and current treatment in patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease following hematopoietic cell transplant or solid organ transplant. Journal of medical economics 27 (1) (2024)
Bérengère Macabeo, Arthur Quenéchdu, Samuel Aballéa, Clément François, Laurent Boyer, Philippe Laramée
Methods for Indirect Treatment Comparison: Results from a Systematic Literature Review. Journal of market access & health policy 12 (2) (2024)
Arie Barlev, Heiner Zimmermann, Norma Guzman-Becerra, Aditi Mehta, Baodong Xing, Bérengère Macabeo, Marion Thivolet, M Alan Brookhart
Comparative analysis of tabelecleucel and current treatment in patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease following hematopoietic cell transplant or solid organ transplant. Journal of medical economics 27 (1) (2024)
Bérengère Macabeo, Arthur Quenéchdu, Samuel Aballéa, Clément François, Laurent Boyer, Philippe Laramée
Methods for Indirect Treatment Comparison: Results from a Systematic Literature Review. Journal of market access & health policy 12 (2) (2024)
Arie Barlev, Heiner Zimmermann, Norma Guzman-Becerra, Aditi Mehta, Baodong Xing, Bérengère Macabeo, Marion Thivolet, M Alan Brookhart
Comparative analysis of tabelecleucel and current treatment in patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease following hematopoietic cell transplant or solid organ transplant. Journal of medical economics (2024)
Bérengère Macabeo, Théophile Rotrou, Aurélie Millier, Clément François, Philippe Laramée
The Acceptance of Indirect Treatment Comparison Methods in Oncology by Health Technology Assessment Agencies in England, France, Germany, Italy, and Spain. PharmacoEconomics - open (2023)
Bérengère Macabeo, Théophile Rotrou, Aurélie Millier, Clément François, Philippe Laramée
The Acceptance of Indirect Treatment Comparison Methods in Oncology by Health Technology Assessment Agencies in England, France, Germany, Italy, and Spain. PharmacoEconomics - open 8 (1) (2023)
Bérengère Macabeo, Théophile Rotrou, Aurélie Millier, Clément François, Philippe Laramée
The Acceptance of Indirect Treatment Comparison Methods in Oncology by Health Technology Assessment Agencies in England, France, Germany, Italy, and Spain. PharmacoEconomics - open 8 (1) (2023)
Bérengère Macabeo, Théophile Rotrou, Aurélie Millier, Clément François, Philippe Laramée
The Acceptance of Indirect Treatment Comparison Methods in Oncology by Health Technology Assessment Agencies in England, France, Germany, Italy, and Spain. PharmacoEconomics - open 8 (1) (2023)
Bérengère Macabeo, Théophile Rotrou, Aurélie Millier, Clément François, Philippe Laramée
The Acceptance of Indirect Treatment Comparison Methods in Oncology by Health Technology Assessment Agencies in England, France, Germany, Italy, and Spain. PharmacoEconomics - open 8 (1) (2023)